(3R,4R)-2'-hydroxy-4',5'-methylenedioxyisoflavan-4,7-diol (CHEBI:142868)

ChEBI > Main

Main

ChEBI Ontology

Automatic Xrefs

Reactions

Pathways

Models

ChEBI Name	(3R,4R)-2'-hydroxy-4',5'-methylenedioxyisoflavan-4,7-diol

ChEBI ID	CHEBI:142868

Definition	A member of the class of hydroxyisoflavans that is isoflavan-4,7-diol which is substituted by a hydroxy group at the 2' position and by a methylenedioxy group at the 4'-5' positions (the R,R stereoisomer).

Stars	This entity has been manually annotated by the ChEBI Team.

Submitter	Kristian Axelsen

Supplier Information

Download	Molfile XML SDF

more structures >>

Formula

C16H14O6

Net Charge

Average Mass

302.282

Monoisotopic Mass

302.07904

InChI

InChI=1S/C16H14O6/c17-8-1-2-9-13(3-8)20-6-11(16(9)19)10-4-14-15(5-12(10)18)22-7-21-14/h1-5,11,16-19H,6-7H2/t11-,16-/m0/s1

InChIKey

VGLBFRZJJZBAST-ZBEGNZNMSA-N

SMILES

C12=CC=C(C=C2OC[C@H]([C@H]1O)C3=C(C=C4C(=C3)OCO4)O)O

ChEBI Ontology
Outgoing	(3R,4R)-2'-hydroxy-4',5'-methylenedioxyisoflavan-4,7-diol (CHEBI:142868) is a benzodioxoles (CHEBI:38298) (3R,4R)-2'-hydroxy-4',5'-methylenedioxyisoflavan-4,7-diol (CHEBI:142868) is a hydroxyisoflavans (CHEBI:76250)

IUPAC Name

(3R,4R)-3-(6-hydroxy-1,3-benzodioxol-5-yl)chromane-4,7-diol

Synonyms	Sources
(3R)-3-(6-hydroxy-2H-1,3-benzodioxol-5-yl)-3,4-dihydro-2H-1-benzopyran-4,7-diol	MetaCyc
(3R,4R)-2'-hydroxy-4',5'-methylenedioxyisoflavan-4,7-diol	ChEBI
(3R,4R)-3-(2-hydroxy-4,5-methylenedioxyphenyl)chromane-4,7-diol	ChEBI
(3R,4R)-3-(6-hydroxy-1,3-benzodioxol-5-yl)-3,4-dihydro-2H-chromene-4,7-diol	UniProt
(3R,4R)-3-(6-hydroxy-1,3-benzodioxol-5-yl)-3,4-dihydro-2H-chromene-4,7-diol	ChEBI
(3R,4R)-3-(6-hydroxy-1,3-benzodioxol-5-yl)chromane-4,7-diol	ChEBI
(3R,4R)-7,2'-dihydroxy-4',5'-methylenedioxyisoflavanol	MetaCyc
(R,R)-3-(6-hydroxy-1,3-benzodioxol-5-yl)chromane-4,7-diol	ChEBI
(R,R)-7,2'-dihydroxy-4',5'-methylenedioxyisoflavanol	ChEBI
cis-(−)-7,2'-dihydroxy-4',5'-methylenedioxyisoflavanol	MetaCyc
cis-(−)-DMDI	MetaCyc

Citation	Type	Source
28394400	PubMed citation	SUBMITTER

Last Modified

15 November 2019